image
Healthcare - Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - REVENUE

Revenue RARE - Ultragenyx Pharmaceutical Inc.

image
434 M
LAST VALUE
11.16%
2 YEAR CAGR
53.18%
5 YEAR CAGR
0.00%
10 YEAR CAGR